Nuragalin-NT Tablet contains a combination of Pregabalin 75 mg and Nortriptyline 10 mg, formulated for the management of neuropathic pain and certain chronic pain conditions. Pregabalin, an anticonvulsant and analgesic agent, modulates calcium channels to reduce neurotransmitter release, thereby alleviating neuropathic pain symptoms such as burning, shooting, or stabbing sensations. Nortriptyline, a tricyclic antidepressant, enhances noradrenergic and serotonergic neurotransmission by inhibiting the reuptake of norepinephrine and serotonin, contributing to its analgesic and mood-stabilizing effects. The combined action of these two agents provides synergistic pain relief, improving patient quality of life in conditions like diabetic neuropathy, postherpetic neuralgia, and fibromyalgia. Nuragalin-NT should be administered as prescribed, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include dizziness, somnolence, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with a history of cardiac arrhythmias, glaucoma, or renal impairment. Concomitant use with other central nervous system depressants may potentiate sedative effects. Regular monitoring and adherence to prescribed dosing are essential to optimize therapeutic outcomes and minimize potential side effects. Nuragalin-NT is intended for use under medical supervision only.